1) Pulmonary inhalation
肺部吸入给药
2) pulmonary delivery
肺部给药
1.
Preparation of 9-Nitrocamptothecin liposome and its pharmacokinetic after pulmonary delivery to rats;
9-硝基喜树碱脂质体的制备及大鼠肺部给药药动学
2.
Novel technologies and mechanisms of enhancing the bioavailability of protein and peptide drugs through pulmonary delivery;
提高蛋白质及多肽类药物肺部给药生物利用度的方法及其作用机制
3.
Advances in pulmonary delivery systems
肺部给药传递系统的研究进展
3) pulmonary drug delivery
肺部给药
1.
Preparation of porous chitosan particles for pulmonary drug delivery;
用于肺部给药的壳聚糖空心微球的制备
2.
Aim To prepare rifapentine(RIF) liposomes modified by surfactants for studying their the water-solubility,drug loading effeciency,release rate and pulmonary drug delivery.
目的制备表面活性剂修饰利福喷丁(R IF)脂质体,进行该脂质体水化性能、载药量、释药速度和肺部给药研究。
3.
Pulmonary drug delivery of liposomes has become one of research foc i in the area of pharmaceutics owing to its specific advantages, such as low irr itation, rapid ab sorption, high bioavailability, satisfactory safety, sustained or controlled rel ease, and so on.
由于脂质体肺部给药具有刺激性小、吸收迅速、生物利用度高、安全性好、可实现持续缓慢释药等独特优势而成为近年来制剂领域的研究热点之一。
4) pulmonary administration
肺部给药
1.
RP-HPLC determination of salbutamol in lung of rats and its application on pulmonary administration;
HPLC荧光检测法测定大鼠肺中沙丁胺醇浓度及其在肺部给药中的应用
5) inhaler
[英][ɪn'heɪlə(r)] [美][ɪn'helɚ]
吸入给药
1.
The dosage forms of inhaled drugs include metered dose inhaler(MDI),dry powder inhaler(DPI)and nebulizer.
目前临床常用吸入给药的剂型包括定量吸入气雾剂(metered dose inhaler,MDI)、吸入粉雾剂/干粉吸入剂(Dry powder inhaler,DPI)和吸入喷雾剂(Nebulizer),这3种吸入给药剂型各有特点。
6) inhalation delivery
吸入式给药
补充资料：麻醉药的吸入浓度
麻醉药的吸入浓度
concentration of inhaled anestheties
指患者吸入气体中麻醉药所占的百分容积比(Vol%)。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条